Extensive serum biomarker analysis in patients with nasopharyngeal carcinoma

Cytokine. 2019 Jun:118:107-114. doi: 10.1016/j.cyto.2018.04.031. Epub 2018 May 11.


Nasopharyngeal carcinoma (NPC) is a fast-growing cancer characterized by high occurrences of nodal and distant metastases and poor prognosis. It is therefore important to identify new serum biomarkers for the early diagnosis and prognostic prediction of this disease. The present study identifies biomarkers in NPC patient serum using a solid-phase antibody array detecting the expression profiles of 174 cytokines in a single experiment. ELISA was performed to validate the array results. The levels of TIMP-2, SELL, CCL24, MMP-1, MMP-3, IGF-I and IL-8 were significantly higher in serum from NPC patients, while the levels of MSP-alpha and HCC-4 were lower. Furthermore, the validation results were identical to those obtained from the antibody array. These results indicate that these cytokines might serve as novel biomarkers for the diagnosis and prognostic prediction of NPC.

Keywords: Antibody array; Nasopharyngeal carcinoma; Serum biomarker.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Biomarkers, Tumor / blood*
  • Case-Control Studies
  • Cytokines / blood
  • Female
  • Humans
  • Male
  • Middle Aged
  • Nasopharyngeal Carcinoma / blood*
  • Nasopharyngeal Neoplasms / blood*
  • Prognosis


  • Biomarkers, Tumor
  • Cytokines